Genetic vs. Environmental Factors in Lung Cancer Development
DOI:
https://doi.org/10.58445/rars.2144Keywords:
Lung cancer, Genetic MutationAbstract
Lung cancer remains a prominent cause of cancer-related mortality worldwide and is characterized by numerous genetic predispositions and environmental factors. This review will highlight how mutations in genes that are components of critical molecular processes influence the development of lung cancer. It will also highlight environmental influences, such as smoking, air pollution and age. Genetic predispositions can significantly increase susceptibility, while environmental exposures can often act as triggers or amplifiers of genes that ultimately result in cancer. Given the substantial impact of lung cancer on human health, understanding how genetic and environmental factors contribute to the development of lung cancer is crucial for advancing personalized medicine and improving population health outcomes.
References
Shi, Yuan-Xiang, De-Qiao Sheng, Lin Cheng, and Xin-Yu Song. 2019. “Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application.” Journal of Oncology 2019 (December):1–11. https://doi.org/10.1155/2019/8107318.
Laguna, Juan Carlos, Marco Tagliamento, Matteo Lambertini, James Hiznay, and Laura Mezquita. 2024. “Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes.” American Society of Clinical Oncology Educational Book 44 (3): e432488. https://doi.org/10.1200/EDBK_432488.
Antonicelli, Alberto, Stefano Cafarotti, Alice Indini, Alessio Galli, Andrea Russo, Alfredo Cesario, Filippo Maria Lococo, et al. 2013. “EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation.” International Journal of Medical Sciences 10 (3): 320–30. https://doi.org/10.7150/ijms.4609.
Lowe, Scott W., and Athena W. Lin. 2000. “Apoptosis in Cancer.” Carcinogenesis 21 (3): 485–95. https://doi.org/10.1093/carcin/21.3.485.
Bethune, Gillian, Drew Bethune, Neale Ridgway, and Zhaolin Xu. 2010. “Epidermal Growth Factor Receptor (EGFR) in Lung Cancer: An Overview and Update.” Journal of Thoracic Disease 2 (1): 48–51.
Fridman, Jordan S, and Scott W Lowe. 2003. “Control of Apoptosis by P53.” Oncogene 22 (56): 9030–40. https://doi.org/10.1038/sj.onc.1207116.
Rizvi, Hira, Francisco Sanchez-Vega, Konnor La, Walid Chatila, Philip Jonsson, Darragh Halpenny, Andrew Plodkowski, et al. 2018. “Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36 (7): 633–41. https://doi.org/10.1200/JCO.2017.75.3384.
Benitez, Dixan A., Guadalupe Cumplido-Laso, Marcos Olivera-Gómez, Nuria Del Valle-Del Pino, Alba Díaz-Pizarro, Sonia Mulero-Navarro, Angel Román-García, and Jose Maria Carvajal-Gonzalez. 2024. “P53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications.” Biomedicines 12 (7): 1453. https://doi.org/10.3390/biomedicines12071453.
Gkountakos, Anastasios, Giulia Sartori, Italia Falcone, Geny Piro, Ludovica Ciuffreda, Carmine Carbone, Giampaolo Tortora, et al. 2019. “PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around.” Cancers 11 (8): 1141. https://doi.org/10.3390/cancers11081141.
Milella, Michele, Italia Falcone, Fabiana Conciatori, Ursula Cesta Incani, Anais Del Curatolo, Nicola Inzerilli, Carmen M. A. Nuzzo, et al. 2015. “PTEN: Multiple Functions in Human Malignant Tumors.” Frontiers in Oncology 5 (February). https://doi.org/10.3389/fonc.2015.00024.
Condoluci, Adalgisa, Calogero Mazzara, Alice Zoccoli, Aldo Pezzuto, and Giuseppe Tonini. 2016. “Impact of Smoking on Lung Cancer Treatment Effectiveness: A Review.” Future Oncology 12 (18): 2149–61. https://doi.org/10.2217/fon-2015-0055.
Jeon, Jihyoun, Theodore R. Holford, David T. Levy, Eric J. Feuer, Pianpian Cao, Jamie Tam, Lauren Clarke, John Clarke, Chung Yin Kong, and Rafael Meza. 2018. “Smoking and Lung Cancer Mortality in the US from 2015-2065: A Comparative Modeling Approach.” Annals of Internal Medicine 169 (10): 684–93. https://doi.org/10.7326/M18-1250.
Cohen, A J. 2000. “Outdoor Air Pollution and Lung Cancer.” Environmental Health Perspectives 108 (suppl 4): 743–50. https://doi.org/10.1289/ehp.00108s4743.
Cohen, A J, and C A Pope. 1995. “Lung Cancer and Air Pollution.” Environmental Health Perspectives 103 (suppl 8): 219–24. https://doi.org/10.1289/ehp.95103s8219.
Sethi, Tarsheen K., Moataz N. El-Ghamry, and Goetz H. Kloecker. 2012. “Radon and Lung Cancer.” Clinical Advances in Hematology & Oncology: H&O 10 (3): 157–64.
Riudavets, Mariona, Marta Garcia De Herreros, Benjamin Besse, and Laura Mezquita. 2022. “Radon and Lung Cancer: Current Trends and Future Perspectives.” Cancers 14 (13): 3142. https://doi.org/10.3390/cancers14133142.
Darby, S., D. Hill, A. Auvinen, J. M. Barros-Dios, H. Baysson, F. Bochicchio, H. Deo, et al. 2005. “Radon in Homes and Risk of Lung Cancer: Collaborative Analysis of Individual Data from 13 European Case-Control Studies.” BMJ (Clinical Research Ed.) 330 (7485): 223. https://doi.org/10.1136/bmj.38308.477650.63.
Herceg, Zdenko, and Thomas Vaissière. 2011. “Epigenetic Mechanisms and Cancer: An Interface between the Environment and the Genome.” Epigenetics 6 (7): 804–19. https://doi.org/10.4161/epi.6.7.16262.
Petrini, Iacopo, and Giuseppe Giaccone. 2022. “Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations.” OncoTargets and Therapy 15 (October):1197–1210. https://doi.org/10.2147/OTT.S329095.
Downloads
Posted
Categories
License
Copyright (c) 2025 Ryan Le
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.